Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 4.99
(0.6%)
CNY 4.99
(0.6%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.17 Billion CNY | -19.68% |
| 2022 | 2.7 Billion CNY | 8.83% |
| 2021 | 2.48 Billion CNY | 0.54% |
| 2020 | 2.47 Billion CNY | -15.98% |
| 2019 | 2.94 Billion CNY | 8.2% |
| 2018 | 2.71 Billion CNY | 17.74% |
| 2017 | 2.3 Billion CNY | -5.13% |
| 2016 | 2.43 Billion CNY | -1.24% |
| 2015 | 2.46 Billion CNY | 86.83% |
| 2014 | 1.31 Billion CNY | 13.65% |
| 2013 | 1.16 Billion CNY | 1.34% |
| 2012 | 1.14 Billion CNY | -11.79% |
| 2011 | 1.29 Billion CNY | 20.83% |
| 2010 | 1.07 Billion CNY | 20.29% |
| 2009 | 893.36 Million CNY | -15.96% |
| 2008 | 1.06 Billion CNY | 2.72% |
| 2007 | 1.03 Billion CNY | 34.36% |
| 2006 | 770.2 Million CNY | 11.5% |
| 2005 | 690.76 Million CNY | 36.49% |
| 2004 | 506.1 Million CNY | 35.41% |
| 2003 | 373.74 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 510.37 Million CNY | -3.42% |
| 2024 Q3 | 405.63 Million CNY | -20.52% |
| 2024 Q1 | 528.46 Million CNY | 6.71% |
| 2023 Q2 | 562.39 Million CNY | -11.3% |
| 2023 Q1 | 634.04 Million CNY | 0.16% |
| 2023 Q4 | 495.25 Million CNY | 3.14% |
| 2023 FY | 2.17 Billion CNY | -19.68% |
| 2023 Q3 | 480.18 Million CNY | -14.62% |
| 2022 Q3 | 603.28 Million CNY | -9.05% |
| 2022 Q1 | 804.52 Million CNY | 15.99% |
| 2022 FY | 2.7 Billion CNY | 8.83% |
| 2022 Q4 | 633.04 Million CNY | 4.93% |
| 2022 Q2 | 663.28 Million CNY | -17.56% |
| 2021 Q4 | 693.63 Million CNY | 15.16% |
| 2021 FY | 2.48 Billion CNY | 0.54% |
| 2021 Q1 | 642.3 Million CNY | 23.7% |
| 2021 Q2 | 546.55 Million CNY | -14.91% |
| 2021 Q3 | 602.32 Million CNY | 10.2% |
| 2020 Q1 | 575.37 Million CNY | 1.75% |
| 2020 Q2 | 732.45 Million CNY | 27.3% |
| 2020 Q3 | 644.3 Million CNY | -12.04% |
| 2020 FY | 2.47 Billion CNY | -15.98% |
| 2020 Q4 | 519.24 Million CNY | -19.41% |
| 2019 Q1 | 831.9 Million CNY | 27.1% |
| 2019 FY | 2.94 Billion CNY | 8.2% |
| 2019 Q4 | 565.45 Million CNY | -12.12% |
| 2019 Q3 | 643.42 Million CNY | -28.56% |
| 2019 Q2 | 900.62 Million CNY | 8.26% |
| 2018 Q1 | 610.75 Million CNY | 4.01% |
| 2018 FY | 2.71 Billion CNY | 17.74% |
| 2018 Q4 | 654.51 Million CNY | -6.25% |
| 2018 Q3 | 698.13 Million CNY | -7.56% |
| 2018 Q2 | 755.2 Million CNY | 23.65% |
| 2017 Q2 | 643.73 Million CNY | 10.18% |
| 2017 Q3 | 493.76 Million CNY | -23.3% |
| 2017 Q1 | 584.23 Million CNY | 10.42% |
| 2017 FY | 2.3 Billion CNY | -5.13% |
| 2017 Q4 | 587.18 Million CNY | 18.92% |
| 2016 Q3 | 618.5 Million CNY | -4.04% |
| 2016 Q1 | 641.7 Million CNY | 9.09% |
| 2016 FY | 2.43 Billion CNY | -1.24% |
| 2016 Q4 | 529.1 Million CNY | -14.45% |
| 2016 Q2 | 644.55 Million CNY | 0.44% |
| 2015 FY | 2.46 Billion CNY | 86.83% |
| 2015 Q4 | 588.2 Million CNY | -1.99% |
| 2015 Q3 | 600.15 Million CNY | -8.47% |
| 2015 Q2 | 655.71 Million CNY | 5.69% |
| 2015 Q1 | 620.41 Million CNY | 29.65% |
| 2014 FY | 1.31 Billion CNY | 13.65% |
| 2014 Q3 | 280.93 Million CNY | -2.9% |
| 2014 Q2 | 289.33 Million CNY | 7.03% |
| 2014 Q4 | 478.54 Million CNY | 70.34% |
| 2014 Q1 | 270.32 Million CNY | -14.7% |
| 2013 Q1 | 296.39 Million CNY | 37.27% |
| 2013 Q2 | 298.14 Million CNY | 0.59% |
| 2013 Q3 | 249.23 Million CNY | -16.41% |
| 2013 Q4 | 316.92 Million CNY | 27.16% |
| 2013 FY | 1.16 Billion CNY | 1.34% |
| 2012 Q4 | 215.91 Million CNY | -24.34% |
| 2012 Q3 | 285.36 Million CNY | -6.37% |
| 2012 FY | 1.14 Billion CNY | -11.79% |
| 2012 Q1 | 339.33 Million CNY | 5.49% |
| 2012 Q2 | 304.76 Million CNY | -10.19% |
| 2011 FY | 1.29 Billion CNY | 20.83% |
| 2011 Q4 | 321.69 Million CNY | 0.32% |
| 2011 Q3 | 320.67 Million CNY | -3.88% |
| 2011 Q2 | 333.62 Million CNY | 3.47% |
| 2011 Q1 | 322.44 Million CNY | 19.36% |
| 2010 Q1 | 254.26 Million CNY | -4.45% |
| 2010 Q3 | 288.51 Million CNY | 10.26% |
| 2010 Q2 | 261.66 Million CNY | 2.91% |
| 2010 FY | 1.07 Billion CNY | 20.29% |
| 2010 Q4 | 270.14 Million CNY | -6.37% |
| 2009 FY | 893.36 Million CNY | -15.96% |
| 2009 Q4 | 266.11 Million CNY | 24.63% |
| 2009 Q3 | 213.52 Million CNY | 3.74% |
| 2009 Q2 | 205.81 Million CNY | -1.01% |
| 2009 Q1 | 207.91 Million CNY | -5.82% |
| 2008 Q1 | 254.55 Million CNY | -8.61% |
| 2008 Q2 | 340.51 Million CNY | 33.77% |
| 2008 Q3 | 247.16 Million CNY | -27.41% |
| 2008 Q4 | 220.76 Million CNY | -10.68% |
| 2008 FY | 1.06 Billion CNY | 2.72% |
| 2007 Q2 | 280.83 Million CNY | 21.92% |
| 2007 FY | 1.03 Billion CNY | 34.36% |
| 2007 Q4 | 278.53 Million CNY | 13.6% |
| 2007 Q3 | 245.17 Million CNY | -12.7% |
| 2007 Q1 | 230.34 Million CNY | 33.1% |
| 2006 Q3 | 180.79 Million CNY | -2.52% |
| 2006 Q4 | 173.06 Million CNY | -4.28% |
| 2006 FY | 770.2 Million CNY | 11.5% |
| 2006 Q2 | 185.46 Million CNY | -19.67% |
| 2006 Q1 | 230.88 Million CNY | 23.92% |
| 2005 FY | 690.76 Million CNY | 36.49% |
| 2005 Q3 | 168.15 Million CNY | 0.0% |
| 2005 Q4 | 186.31 Million CNY | 10.8% |
| 2004 FY | 506.1 Million CNY | 35.41% |
| 2003 FY | 373.74 Million CNY | 0.0% |